Last update :
19/11/2024
Immunosuppressant   Natalizumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Tysabri Argentina, Australia, Belgium, Canada, Chile, Colombia, Denmark, Ecuador, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Italy, Mexico, Morocco, Netherlands, Norway, Peru, Poland, Romania, Slovenia, Spain, Sweden, Switzerland, Turkey, United States of America
Stability in solutions   injection   Stability in solutions : Natalizumab     
Container Solvent Concentration Temperature Storage Duration of stability References
Not specified Sodium chloride 0,9% 2,6 mg/mL 2-8°C Not specified
8 Hour
4068
Manufacturer's stability data


  Mentions Légales